Research Project
Grant-in-Aid for Scientific Research (C)
The purpose is to examine the role of a downstream signal system of EGFR in detail for clarifying factors other than the EGFR gene variation which determines the susceptibility of the medicine, and considering existence of the hereditary individual difference of the course. We planned clinical trial which prescribes erlotinib for the patient as second line treatment for a non-small-cell-lung-cancer case with a wild type EGFR gene, and performingbiomarker search by a cDNA microarray and RT-PCR.It checked that RNA extraction of the high purity of a tumor was possible from the minute biopsy sample of puncture under the ultrasound endoscopy (EBUS), and established the method of conducting DNA microarray analysis efficiently from a clinical sample. Furthermore, fundamental study was performed using the non-small-cell-lung-cancer-cells and mesothelioma-cells stock for the purpose of clarifying biological significance relevant to the effect of Erlotinib. Thymidylate synthase expression did not necessarily correlate with pemetrexed resistance. Metformin inhibited the proliferation of various histological types of human lung cancer cell lines, possibly by varied mechanisms including apoptosis induction and G0/G1 arrest according to the cell line.
All 2012 2011 2010
All Journal Article (32 results) (of which Peer Reviewed: 21 results) Presentation (6 results)
Oncology Reports
Volume: 28(1) Pages: 8-14
10.3892/or.2012.1763
Volume: 28(1) Pages: 33-40
10.3892/or.2012.1799
Respiratory Investigation
Volume: 50(2) Pages: 46-53
Sarcoidosis, Vasculitis, And Diffuse Lung Diseases: Official Journal Of WASOG / World Association Of Sarcoidosis And Other Granulomatous Disorders
Volume: 29(2) Pages: 82-89
CEN Case Rep
Volume: 1 Pages: 90-95
Cancer Gene Ther
Volume: 19 Issue: 3 Pages: 218-228
10.1038/cgt.2011.86
Cellular Immunology
Volume: 275(1-2) Issue: 2 Pages: 90-97
10.1016/j.resinv.2012.04.002
American Journal of Physiology
Volume: 303 Issue: 2 Pages: 141-151
10.1152/ajplung.00337.2011
Oncol Rep
Volume: 25(3) Issue: 3 Pages: 637-644
10.3892/or.2010.1131
Cancer Sci
Volume: 102 Issue: 7 Pages: 1366-73
10.1111/j.1349-7006.2011.01931.x
10029295478
Mycopathologia
Volume: 172(1) Pages: 5-15
International Journal Of Clinical Oncology / Japan Society Of Clinical Oncology
Volume: 16(6) Pages: 770-773
10030247775
Surgery Today
Volume: 41(7) Pages: 914-921
10029048516
Japanese Journal Of Clinical Oncology
Volume: 41(8) Pages: 935-936
Journal Of Thoracic Oncology: Official Publication Of The International Association For The Study Of Lung Cancer
Volume: 6(1) Pages: 156-160
Head & Neck
Volume: 33(3) Issue: 3 Pages: 309-317
10.1002/hed.21445
Journal Of Thoracic Oncology : Official Publication Of The International Association For The Study Of Lung Cancer
Volume: 6(1) Issue: 1 Pages: 156-160
10.1097/jto.0b013e3181f7c76a
International Journal Of Cardiology
Volume: 146(3) Issue: 3 Pages: 449-450
10.1016/j.ijcard.2010.10.115
Journal of Thoracic Oncology : Official Publication of The International Association For The Study of Lung Cancer
Volume: 25(3) Pages: 637-644
International Journal of Cardiology
Volume: 146(3) Pages: 449-450
Jpn J Clin Oncol
Volume: 40(5) Issue: 5 Pages: 464-469
10.1093/jjco/hyp190
Lung Cancer
Volume: 69(2) Issue: 2 Pages: 213-217
10.1016/j.lungcan.2009.10.017
Volume: 68(3) Issue: 3 Pages: 409-14
10.1016/j.lungcan.2009.08.009
Volume: 23(1) Issue: 1 Pages: 61-7
10.3892/or_00000606
Volume: 40(10) Issue: 10 Pages: 923-930
10.1007/s00595-009-4196-1
Volume: 68(3) Pages: 409-414
Volume: 23(1) Pages: 61-67
Volume: 40(10) Pages: 923-930
Lung Cancer (Amsterdam, Netherlands)
Volume: 69(2) Pages: 213-217
Volume: 40(5) Pages: 464-469